
Investornewsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) To Present At H.C. Wainwright Global Investment Conference
(MENAFN- Investor Brand Network) Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8–10, 2025, …